Zombie bacteria in tuberculosis

January 26, 2015, Ecole Polytechnique Federale de Lausanne

Mycobacterium tuberculosis. Credit: CDC/Elizabeth "Libby" White
"Living-dead" bacteria exist in limbo: biologically active but not proliferating. Buried in this zombie state, disease-causing bacteria could come back from the dead to re-infect patients. Researchers at EPFL have produced the first evidence of this strange phenomenon in tuberculosis, suggesting new avenues for treatment.

Tuberculosis affects over 12 million people globally, and is usually treated with a course of four drugs over several months. However, even after completing the treatment, many patients suffer relapses. Based on studies of harmless environmental bacteria, scientists think that the , Mycobacterium tuberculosis, retreats into a bizarre "zombie" state in the patient's body, and comes back to life when the conditions permit. Scientists at EPFL have now made the first of M. tuberculosis in this zombie state, which seems to be amplified by stressful conditions such as attacks from the host's . The work, which points to entirely new pathways for treating tuberculosis, is published in Cell Host & Microbe.

Living bacteria divide and proliferate; if not, they are considered dead. However, some bacteria can go into a strange, in-between state where they are biologically active – producing energy and making proteins – but do not divide. "It's a kind of living-dead, zombie existence," says John McKinney, whose postdoc, Giulia Manina, led the study on M. tuberculosis. "The bacteria are somewhat active, but they're neither growing nor dividing. We refer to this state as 'Non-Growing but Metabolically Active' or 'NGMA'".

This state is thought to underlie the relapse of tuberculosis: when the population of M. tuberculosis infecting a patient is faced with an aggressive antibiotic regimen, a part of it falls into this zombie state as a defense mechanism. However, there has been little evidence to support this theory, partly because experimental techniques for studying bacterial populations usually depend on the bacteria actually growing in the first place.

There is, however, a way in: the zombie bacteria are still metabolically active, which means that they keep making new proteins. Manina exploited this with a technique that can tag and track a gene that turns on when M. tuberculosis makes new proteins. The technique, developed by the lab's senior scientist, Neeraj Dhar, tags the gene with a fluorescent molecule that can be tracked with a microscope over time.

Manina grew the gene-tagged bacteria under different stressful conditions such as limited nutrients, antibiotics, and also conditions that simulate an attack by the patient's immune system. In addition, bacteria were taken from the lungs of infected mice at different stages of infection. Tracked with the fluorescent gene-tag, the were tested to see how the different conditions affected them over time.

The researchers found that M. tuberculosis responds to like immune attacks or lack of nutrients by diversifying its population and pushing some it into the zombie state. "This means that this state could be a defensive response to the patient's immunity," says Manina. "What is unclear at the moment is whether it is an active bacterial response, or just a consequence of an immune attack."

In addition, the researchers found that the lungs of mice with tuberculosis contained an unexpectedly large subpopulation of zombie cells. Surprisingly, these cells were not found in mice that were genetically modified to lack an immune system, further suggesting that the immune system and the zombie state are somehow related.

The scientists think that this phenomenon could contribute to the bacterium's antibiotic resistance, and that immunity and drug pressure may contribute to the persistence and relapse of tuberculosis. Consequently, these findings could be used to develop novel drug strategies against M. , especially targeting the non-replicating, zombie cells. The group is currently interested in optimizing their gene-tracking techniques and getting a clearer picture of the underlying physiology of the zombie state.

Explore further: Tuberculosis avoids and subverts host immunity

More information: Manina G, Dhar N, McKinney JD. "Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms." Cell Host & Microbe (2015), dx.doi.org/10.1016/j.chom.2014.11.016

Related Stories

Tuberculosis avoids and subverts host immunity

December 23, 2014
An ancient disease, tuberculosis (TB) continues to be one of the major causes of disability and death worldwide. The recent TB cases in Quebec among the Inuit community has underscored the need to find new avenues to eradicate ...

New weapons against multidrug resistance in tuberculosis

October 8, 2014
Using a high-throughput screening assay, EPFL scientists have discovered two small molecules that could overcome the multidrug resistance of the bacterium that causes tuberculosis.

Lung lesions of TB variable, independent whether infection is active or latent

December 15, 2013
The lung lesions in an individual infected with tuberculosis (TB) are surprisingly variable and independent of each other, despite whether the patient has clinically active or latent disease, according to a new animal study ...

Guam students to be tested for tuberculosis

December 30, 2014
Students at five Guam schools who were exposed to a bus driver with tuberculosis will be tested for the disease.

FDA approves first new tuberculosis in 40 years

December 31, 2012
The Food and Drug Administration says it has approved a Johnson & Johnson tuberculosis drug that is the first new medicine to fight the deadly infection in more than four decades.

Optofluidics reveals new strategy for bacteria antibiotic resistance

January 3, 2013
Scientists used microfluidics to observe the behavior of individual tuberculosis-like bacteria in the presence of antibiotics. Their observations call into question the prevailing theory of bacterial resistance, and they ...

Recommended for you

A versatile vaccine that can protect mice from emerging tick-borne viruses

December 18, 2018
A group of researchers led by Michael Diamond of Washington University School of Medicine in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause ...

How cholera bacteria make people so sick

December 18, 2018
The enormous adaptability of the cholera bacterium explains why it is able to claim so many victims. Professor Ariane Briegel from the Leiden Institute of Biology has now discovered that this adaptability is due to rapid ...

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.